About ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate
ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate (PubChem CID 166805223) has the molecular formula C29H38FN3O3
and a molecular weight of 495.64 g/mol. Its IUPAC name is ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate.
Molecular Properties
| Compound Name | ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate |
| PubChem CID | 166805223 |
| Molecular Formula | C29H38FN3O3 |
| Molecular Weight | 495.64 g/mol |
| Exact Mass | 495.29 |
| IUPAC Name | ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate |
| SMILES | C=C(/C=C1/N=C(C(=O)N(C)C(C)CCCC)C=C(CC)N1C)c1cccc(/C=C/C(=O)OCC)c1F |
| InChI | InChI=1S/C29H38FN3O3/c1-8-11-13-21(5)32(6)29(35)25-19-23(9-2)33(7)26(31-25)18-20(4)24-15-12-14-22(28(24)30)16-17-27(34)36-10-3/h12,14-19,21H,4,8-11,13H2,1-3,5-7H3/b17-16+,26-18- |
| InChIKey | GRNQXIBEZVTBHO-WQEYKGBFSA-N |
| XLogP | 5.97 |
| TPSA | 62.21 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 495.64 |
| LogP ≤ 5 | 5.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate?
The IUPAC name of ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate (CID 166805223) is ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate.
What is the SMILES notation for ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate?
The canonical SMILES for ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate is C=C(/C=C1/N=C(C(=O)N(C)C(C)CCCC)C=C(CC)N1C)c1cccc(/C=C/C(=O)OCC)c1F.
What is the InChIKey of ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate?
The InChIKey is GRNQXIBEZVTBHO-WQEYKGBFSA-N. The full InChI is InChI=1S/C29H38FN3O3/c1-8-11-13-21(5)32(6)29(35)25-19-23(9-2)33(7)26(31-25)18-20(4)24-15-12-14-22(28(24)30)16-17-27(34)36-10-3/h12,14-19,21H,4,8-11,13H2,1-3,5-7H3/b17-16+,26-18-.
What are the key properties of ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate?
ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate has a molecular weight of 495.64 g/mol, XLogP of 5.97, 11 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl (E)-3-[3-[(3E)-3-[6-ethyl-4-[hexan-2-yl(methyl)carbamoyl]-1-methylpyrimidin-2-ylidene]prop-1-en-2-yl]-2-fluorophenyl]prop-2-enoate is sourced from PubChem (CID 166805223), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).